Search Legislation

Commission Regulation (EC) No 1490/2002Show full title

Commission Regulation (EC) No 1490/2002 of 14 August 2002 laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and amending Regulation (EC) No 451/2000 (Text with EEA relevance) (revoked)

 Help about what version

What Version

 Help about opening options

Opening OptionsExpand opening options

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Changes to legislation:

There are currently no known outstanding effects by UK legislation for Commission Regulation (EC) No 1490/2002. Help about Changes to Legislation

  1. Introductory Text

  2. Article 1.Subject matter and scope

  3. Article 2.Definitions

  4. Article 3.Member State authority

  5. Article 4.Measures in case of imbalances

  6. Article 5.Withdrawal or replacement of notifier

  7. Article 6.Submission and checking of data lists

  8. Article 7.Submission of dossiers

  9. Article 8.Submission of information by third parties

  10. Article 9.Completeness check of dossiers

  11. Article 10.Evaluation by the rapporteur Member State

  12. Article 11. Receipt of and access to the draft assessment report

  13. Article 11a. Examination of the draft assessment report

  14. Article 11b. Active substance with clear indications that they do not have any harmful effects

  15. Article 11c. Consultation of the EFSA

  16. Article 11d. Submission of additional information after the draft assessment report has been submitted to the EFSA

  17. Article 11e. Withdrawal by notifier

  18. Article 11f. Active substance for which there are clear indications of harmful effects

  19. Article 12. Presentation of a draft directive or draft decision

  20. Article 12a. View by the EFSA

  21. Article 13.Finalised review report

  22. Article 14.Suspension of time limits

  23. Article 15.Measures taken by Member States

  24. Article 16.Interim progress report

  25. Article 17.Fees

  26. Article 18.Other charges, taxes, levies or fees

  27. Article 19.Temporary measures

  28. Article 20.Amendment to Regulation (EC) No 451/2000

  29. Article 21.Entry into force

  30. Signature

    1. Expand +/Collapse -

      ANNEX I

      List of active substances (column A), rapporteur Member States (column B) and notifying producers (code identification) (column C)

      1. PART A

      2. PART B

    2. Expand +/Collapse -

      ANNEX II

      List of notifiers' code identification, names and addresses

    3. Expand +/Collapse -

      ANNEX III

      Coordinating authority in the Member States (more details are available at the following website: http://www.europa.eu.int/comm/food/fs/ph_ps/pro/index_en.htm)

      1. AUSTRIA

      2. BELGIUM

      3. DENMARK

      4. GERMANY

      5. GREECE

      6. SPAIN

      7. FINLAND

      8. FRANCE

      9. IRELAND

      10. ITALY

      11. LUXEMBOURG

      12. NETHERLANDS

      13. PORTUGAL

      14. SWEDEN

      15. UNITED KINGDOM

    4. Expand +/Collapse -

      ANNEX IV

      Organisations in the Member States to be contacted concerning further details on the payment of the fees referred to in Article 17 and to which such fees have to be paid

      1. AUSTRIA

      2. BELGIUM

      3. DENMARK

      4. GERMANY

      5. GREECE

      6. SPAIN

      7. FINLAND

      8. FRANCE

      9. IRELAND

      10. ITALY

      11. LUXEMBOURG

      12. THE NETHERLANDS

      13. PORTUGAL

      14. SWEDEN

      15. UNITED KINGDOM

    5. Expand +/Collapse -

      ANNEX V

      Criteria for clear indications of no harmful effects

      1. An active substance shall be considered as fulfilling the requirement,...

      2. 1. The active substance satisfies the following criteria:

      3. 2. At least one supported representative use of the active substance...

    6. Expand +/Collapse -

      ANNEX VI

      Criteria for clear indications of harmful effects

      1. An active substance shall be considered as fulfilling the requirement,...

      2. 1. As regards the active substance, the existing evidence is not...

      3. 2. As regards each supported representative use, at least one of...

Back to top

Options/Help